Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-17-003385
Filing Date
2017-01-20
Accepted
2017-01-20 17:27:29
Documents
91
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a16-22709_110ka.htm 10-K/A 2204363
2 EX-23.1 a16-22709_1ex23d1.htm EX-23.1 5128
3 EX-23.2 a16-22709_1ex23d2.htm EX-23.2 4554
4 EX-31.1 a16-22709_1ex31d1.htm EX-31.1 12429
5 EX-31.2 a16-22709_1ex31d2.htm EX-31.2 12443
6 EX-32.1 a16-22709_1ex32d1.htm EX-32.1 5833
7 EX-32.2 a16-22709_1ex32d2.htm EX-32.2 5852
14 GRAPHIC g227091bki001.jpg GRAPHIC 22778
15 GRAPHIC g227091bsi001.jpg GRAPHIC 18314
  Complete submission text file 0001104659-17-003385.txt   9648297

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT supn-20151231.xml EX-101.INS 2095229
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20151231.xsd EX-101.SCH 67094
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20151231_cal.xml EX-101.CAL 86218
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20151231_def.xml EX-101.DEF 265954
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20151231_lab.xml EX-101.LAB 684885
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20151231_pre.xml EX-101.PRE 492854
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-K/A | Act: 34 | File No.: 001-35518 | Film No.: 17539339
SIC: 2834 Pharmaceutical Preparations